<DOC>
	<DOCNO>NCT00861159</DOCNO>
	<brief_summary>It investigators aim determine feasibility directly detect anti-RLIP76 auto-antibodies human serum use prepared RLIP76 antigen peptide person rheumatologic disease person without rheumatologic diesease ( `` healthy subject '' ) .</brief_summary>
	<brief_title>RLIP76 Human Serum Adults With Rheumatologic Diseases</brief_title>
	<detailed_description>This exploratory study conduct see feasibility measure anti-RLIP76 antibody standardize method measurement . We perform study blood sample obtain human subject inform concent blood draw research purpose obtain Clinical Research Co-ordinator ( CRC ) .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<criteria>Adult ( age 18+ ) , nonpregnant subject previously diagnose rheumatologic disease candidate study . Children , pregnant woman , prisoner , person medical condition precludes phlebotomy , patient unwilling unable provide consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>RLIP76 Auto Antibodies</keyword>
</DOC>